PDF-read only
Correspondence
Published on 22 Dec 2023
Allergic contact dermatitis caused by Dermabond® Advanced: The role of temperature as a potential risk factor
Journal of Cutaneous Immunology and Allergy
doi 10.1002/cia2.12328
Type at least 3 characters
376 articles
Articles
PDF-read only
Correspondence
Published on 22 Dec 2023
A case of methotrexate‐related lymphoproliferative disorder resolved with discontinuation of the drug: A literature review for clinical characteristics in 105 Japanese cases
Journal of Cutaneous Immunology and Allergy
doi 10.1002/cia2.12324
PDF-read only
Case Study
Published on 22 Dec 2023
Two cases of acute‐onset cystoid macular edema and serous retinal detachment associated with combined use of encorafenib and binimetinib for advanced melanoma: A possible confounding risk for drug intolerance
Journal of Cutaneous Immunology and Allergy
doi 10.1002/cia2.12325
PDF-read only
Correspondence
Published on 22 Dec 2023
Nail toxicity with nail bed ulceration associated with pembrolizumab
Journal of Cutaneous Immunology and Allergy
doi 10.1002/cia2.12301
PDF-read only
Case Study
Published on 22 Dec 2023
A case of myasthenia gravis following alopecia areata
Journal of Cutaneous Immunology and Allergy
doi 10.1002/cia2.12327
PDF-read only
Case Study
Published on 22 Dec 2023
The presence of neutrophil extracellular traps in different forms of pyoderma gangrenosum
Journal of Cutaneous Immunology and Allergy
doi 10.1002/cia2.12331
PDF-read only
Correspondence
Published on 22 Dec 2023
Stevens‐Johnson syndrome without skin lesions extensively involving the digestive tract
Journal of Cutaneous Immunology and Allergy
doi 10.1002/cia2.12323
PDF-read only
Correspondence
Published on 22 Dec 2023
Effectiveness of upadacitinib in Japanese patients with prurigo‐type atopic dermatitis: Four cases report
Journal of Cutaneous Immunology and Allergy
doi 10.1002/cia2.12333
PDF-read only
Original Research
Published on 22 Dec 2023
Decreased CXCL14 expression in psoriasis recovered by narrow‐band ultraviolet B therapy
Journal of Cutaneous Immunology and Allergy
doi 10.1002/cia2.12332
PDF-read only
Correspondence
Published on 22 Dec 2023
Brentuximab vedotin treatment for mycosis fungoides with CD30+ large‐cell transformation in the early stage
Journal of Cutaneous Immunology and Allergy
doi 10.1002/cia2.12330
PDF-read only
Case Study
Published on 22 Dec 2023
Pityriasis rubra pilaris following administration of SARS‐CoV‐2 vaccine
Journal of Cutaneous Immunology and Allergy
doi 10.1002/cia2.12326
PDF-read only
Other
Published on 22 Dec 2023
Issue Information
Journal of Cutaneous Immunology and Allergy
doi 10.1002/cia2.12257
PDF-read only
Original Research
Published on 12 Oct 2023
Cutaneous arteritis: Clinicopathological study of 21 cases
Journal of Cutaneous Immunology and Allergy
doi 10.1002/cia2.12305
PDF-read only
Correspondence
Published on 12 Oct 2023
A case of disseminated erythematous drug eruption caused by favipiravir in a patient with COVID‐19
Journal of Cutaneous Immunology and Allergy
doi 10.1002/cia2.12321
PDF-read only
Correspondence
Published on 12 Oct 2023
Dupilumab aggravates Sézary syndrome: The importance of accurate pathological diagnosis
Journal of Cutaneous Immunology and Allergy
doi 10.1002/cia2.12311
PDF-read only
Original Research
Published on 12 Oct 2023
Improvements in self‐confidence and satisfaction with self‐injection after introducing self‐injection of dupilumab in patients with atopic dermatitis
Journal of Cutaneous Immunology and Allergy
doi 10.1002/cia2.12313